AI assistant
Sending…
Personalis, Inc. — Director's Dealing 2020
Mar 11, 2020
32721_dirs_2020-03-11_4b56aabd-b7d1-459b-be36-c441fdbfc63d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Personalis, Inc. (PSNL)
CIK: 0001527753
Period of Report: 2020-02-25
Reporting Person: Chen Richard (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-25 | Common Stock | M | 101000 | $0.00 | Acquired | 160000 | Direct |
| 2020-02-25 | Common Stock | S | 101000 | $8.77 | Disposed | 59000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | Stock Option (right to buy) | $0.44 | M | 101000 | Disposed | 2022-03-07 | Common Stock (101000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The weighted average sale price for the transaction reported was $8.77, and the range of prices were between $8.445 and $9.29 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F3: The Shares subject to the option are fully vested and exercisable.
More from Personalis, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26